Neuroengineering Postdoctoral Researcher

As a flagship research center in nanoscience and nanotechnology, our mission is to open and explore new frontiers of knowledge at the nanoscale, and bring value to society in the form of new understanding, capabilities and innovation, while inspiring and providing broad training to the next generations of researchers. Our values are Commitment, Collaboration and Transformation.

Our research lines focus on the newly-discovered physical and chemical properties that arise from the behaviour of matter at the nanoscale. ICN2 has been awarded with the Severo Ochoa Center of Excellence distinction for three consecutive periods  and  and ). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different areas of nanoscience and nanotechnology.

Nanomedicine Group

The Nanomedicine Lab aims to generate and disseminate fundamental knowledge in the field of nanomedicine by bringing together nanotechnology, bioengineering, pharmacology and their translation to advanced, clinically-relevant therapeutics and diagnostics.

Our mission is to pioneer the cutting‑edge and emerging discipline of nanomedicine by bringing advanced materials and nanoscale platforms to the clinic.

• Nanomaterials as transport systems for therapeutic and diagnostic applications against cancer and neurodegenerative disease
• Translation of advanced materials to the clinic
• Discovery of novel liposome and vesicle systems to be used as components of therapeutics in oncology and neurology
• Neurotechnology based on flexible, thin‑film technologies for therapeutic applications in oncology and neurology

The Nanomedicine Lab has been awarded one of the prestigious ERC Synergy Grants to co‑develop the SKIN2

DTRONICS project, which aims to develop ultra‑conformable, soft and thin (skin‑like) electronic devices using two‑dimensional materials and revolutionise brain cancer monitoring and detection of tumour recurrence. This is a collaborative effort with colleagues from Università di Pisa, Instituto de Ciencia de Materiales de Madrid‑CSIC, and École Polytechnique Fédérale de Lausanne.

The Nanomedicine Lab has strong collaborative links and projects with the Center for Nanotechnology in Medicine at the Faculty of Biology, Medicine and Health of The University of Manchester in the United Kingdom.

The candidate will work in the development and assessment of neurotechnology aimed for invasive brain‑computer interfaces. In particular, the work will include in vitro assessment of the performance of electrophysiology neural probes for recording and stimulation (electrochemical characterization of impedance, charge injection limit, etc.) and the preparation and execution of in vivo electrophysiology experiments (animal models) in collaboration with experimental neuroscientists.

A central task and responsibility of the candidate will be to lead and execute the analysis of electrophysiological data (signal quality, biomarker detection, etc.) obtained from pre‑clinical studies and investigations using different disease models. The post does not require the candidate to hold a license for pre‑clinical model experimentation.

• Maintain expertise in scientific developments relevant to the objectives of the Nanomedicine Lab and the project and provide relevant expert advice in the area of neuroengineering
• Expected to have an active participation in Nanomedicine Lab scientific activities (lab meetings, seminars, project meetings, etc.)
• Actively read the scientific literature relating to (and around) the project
• Provide clear and timely written work, producing reports and publishing in high quality publications. This may include presentations at national or international level and outreach activities
• Train students, researchers, collaborators and new personnel
• Coordinate and execute studies with other researchers among the Nanomedicine Lab members
• Collate and store accurate records using paper…